Triethylamine → HCID 77846074, compound
Reaction equation
[F:1][C:2]1[C:3]2[CH:4]=[C:5]3[C:14]4[N:15]=[C:16]([C:19]5[C:20]([N:35]([CH3:40])[S:36]([CH3:39])(=[O:38])=[O:37])=[CH:21][C:22]6[O:26][C:25]([C:27]([OH:29])=O)=[C:24]([C:30](=[O:33])[NH:31][CH3:32])[C:23]=6[CH:34]=5)[CH:17]=[CH:18][C:13]=4[O:12][CH2:11][N:6]3[C:7]=2[CH:8]=[CH:9][CH:10]=1.C1C=CC2N(O)N=[N:47][C:45]=2C=1.CCN=C=NCCCN(C)C.Cl.CN.CCN(CC)CC>CN(C=O)C>[F:1][C:2]1[C:3]2[CH:4]=[C:5]3[C:14]4[N:15]=[C:16]([C:19]5[C:20]([N:35]([CH3:40])[S:36]([CH3:39])(=[O:37])=[O:38])=[CH:21][C:22]6[O:26][C:25]([C:27]([NH:47][CH3:45])=[O:29])=[C:24]([C:30]([NH:31][CH3:32])=[O:33])[C:23]=6[CH:34]=5)[CH:17]=[CH:18][C:13]=4[O:12][CH2:11][N:6]3[C:7]=2[CH:8]=[CH:9][CH:10]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of compound 5-(11-fluoro-6H-pyrido[2′,3′:5,6][1,3]oxazino[3,4-a]indol-2-yl)-3-(methylcarbamoyl)-6-(N-methylmethylsulfonamido)benzofuran-2-carboxylic acid (50 mg, 0.09 mmol), HOBT (24 mg, 0.17 mmol), EDCI (102 mg, 0.53 mmol), methanamine hydrochloride (42 mg, 0.62 mmol) and Et3N (72 mg, 0.71 mmol) in DMF (2 mL) was stirred overnight at room temperature. The reaction mixture was concentrated in vacuo, the residue was purified by prep-TLC (DCM:MeOH=200:1) to give the product 5-(11-fluoro-6H-pyrido[2′,3′:5,6][1,3]oxazino[3,4-a]indol-2-yl)-N2,N3-dimethyl-6-(N-methylmethylsulfonamido)benzofuran-2,3-dicarboxamide (20 mg, yield: 39%). 1H NMR (CDCl3, 400 MHz) δ 10.49 (br s, 1H), 8.81 (s, 1H), 7.68 (s, 1H), 7.49 (s, 2H), 7.24˜7.17 (m, 3H), 7.12 (d, J=8.2 Hz, 1H), 6.88˜6.81 (m, 1H), 6.01 (s, 2H), 3.39 (s, 3H), 3.12 (d, J=5.2 Hz, 3H), 3.02 (d, J=4.8 Hz, 3H), 2.65 (s, 3H). MS (M+H)+: 578.
Workup
- concentrationThe reaction mixture was concentrated in vacuo
- customthe residue was purified by prep-TLC (DCM:MeOH=200:1)
Sources & evidence
- ORD record
- ord-2fafe1cef7784316b18dd05f86536582
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09242998B2
Reaction notes
Loading…